Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
10,966 total articles
Aquestive's Anaphylm clinical readouts and renewed investor engagement suggest the company is closer to resolving prior FDA deficiencies. The stock at $4.25 offers a risk-reward setup if management can translate recent data and conference activity into constructive FDA dialogue. This trade idea outlines a mid-term long with an entry at $4.20, a sto…
Riley Exploration Permian (REPX) is trading at a low P/E and attractive dividend yield while generating solid free cash flow and returns on capital. Operational catalysts tied to Permian acreage development and a push into 2026 production growth justify a long trade: entry at $32.05, stop at $27.00, target $44.00 over a 180-trading-day horizon.
Immunome (IMNM) is a clinical-stage antibody developer trading at a $2.4B+ market cap despite negative earnings and a large negative free cash flow. If the market is right about an upcoming NDA-related run, shares have room to move toward the analyst consensus near $30. This trade pairs a tactical long entry at $22.00 with a $30.00 target and tight…
Cigna has delivered repeated earnings beats and raised dividends, yet shares have sold off amid PBM scrutiny and an active short interest. Fundamentals - including $8.4B free cash flow and a sub-12x P/E - argue the stock is cheap enough for a tactical long. This trade targets a mid-term rebound while respecting regulatory and margin risks.
Kirby Corporation (KEX) offers a measured long opportunity. The company combines solid free cash flow generation, modest leverage and recent board-level share repurchase authorization with a stock trading below its short-term momentum bands. This trade idea targets a near-term rebound toward resistance near $135 while keeping downside risk capped w…
ASML sits at the top of the semiconductor capital-equipment stack. With EUV lithography essential for leading-edge chips used in AI, the company's scale, recent buybacks and continued 2025 profit growth support a long bias. This trade outlines an entry at current levels, a mid-target, a longer-term target, and a clear stop, with catalysts and count…
Sphere Entertainment ($SPHR) pulled back into the $114–$120 area after hitting a 52-week high of $121.93. The business now trades with meaningful free cash flow, a manageable debt profile, and strong event-driven revenue potential. For traders willing to hold into the next year of venue rollouts and potential MSG Network simplification, a long posi…
United Natural Foods (UNFI) fell after mixed Q2 results and a trimmed sales guide, but the company's strong adjusted EPS beat, meaningful free cash flow ($344M), and strikingly low price-to-sales (~0.07) argue this pullback is a tactical buy for a mid-term upgrade. We'll lay out an entry, stop and target for a mid-term trade and the scenarios that …
TMC’s consolidated NOAA application expanding its applied-for commercial recovery zone from ~25,000 km2 to ~65,000 km2 materially increases the resource optionality investors can value today. At a $6.39 stock price and ~$2.64B market cap, the market has priced in progress but not full permit upside nor continuing operational execution risk. This tr…
Green Thumb (GTBIF) is trading below recent moving averages but shows improving momentum and an attractive valuation profile (market cap $1.50B, P/E ~13.5, PB ~0.79). With continued retail expansion, margin rehabilitation potential and lighter short interest versus late-2025 peaks, this is a high-conviction swing idea to lock in a consolidation mov…
Hims & Hers (HIMS) just removed a major legal overhang with Novo Nordisk and announced a $1.15B acquisition to accelerate international expansion. The combination re-prices optionality into the shares even as GLP-1 demand normalizes. This trade plan targets a mid-term rebound while protecting against renewed GLP-1 weakness or execution risk.
Wizz Air is unusually exposed to jet-fuel swings and capacity shifts in Central and Eastern Europe. If oil prices normalize from elevated levels, WIZZ should enjoy a disproportionate recovery in margins and cash flow. This trade idea lays out a long entry, explicit targets and stops, catalysts to watch, and the risks that could derail the thesis.
i-80 Gold (IAUX) is a developer-producer positioned to re-rate in 2026. Market cap sits around $1.55B, cash per share is about $0.46 and the company recently strengthened its balance sheet with a $160M bought deal. With gold demand at record levels and operational optimization driving margin expansion, i-80 is a high-conviction long for investors w…
H&R Block is trading near its 52-week low with a sub-7x P/E, strong free cash flow and a durable dividend. For patient traders looking for value plus income, HRB offers skewed risk/reward over the next 180 trading days.
Devon Energy looks cheap on headline multiples, but the market has already priced in generous merger synergies, dividend hikes and buybacks. With legal scrutiny, integration risk, and a near-term ex-dividend date, there's a tactical opportunity to short into strength for a mid-term trade (45 trading days). Entry $44.00, target $38.00, stop $47.00.
Mosaic (MOS) is one of the largest U.S.-based producers of phosphate and potash fertilizers. With agriculture fundamentals supportive, constrained new supply, and a business that generates strong operating cash flow in commodity cycles, MOS offers an actionable long trade for investors who want exposure to fertilizer tightness without betting on si…
REalloys (ALOY) is a vertically integrated U.S. rare-earth-to-magnet company with a sub-4M float, a recent upsized $50M offering, and clear catalysts that could push the stock higher over the next 45 trading days. The setup is high-risk but actionable: buy into momentum with a tight stop and a realistic target below the 52-week high to account for …
Evotec (EVO) is trading near its 52-week low with oversold technicals (RSI ~28) while the outsourced biologics and antibody discovery markets are forecast to expand materially. With a market cap just under $1.0B and a PB of ~1.14, the setup favors a tactical long for mean reversion into improving industry tailwinds. This trade idea lays out entry, …
Chewy ($CHWY) is a defensive consumer platform with sticky Autoship demand and improving profitability. At roughly $25.80 today and a market cap near $10.7B, the stock offers a mission-capable risk/reward for a mid-term bounce toward $34.00. This trade plan uses a precise entry, stop and target with a 45-trading-day horizon, framed around cash flow…
Dianthus' go decision to advance its CIDP program materially de-risks a previously binary story. For traders and active investors willing to accept biotech volatility, we recommend a buy with a clearly defined entry at $4.50, stop at $2.75 and initial target at $9.00 over a mid-term horizon (45 trading days).
MYR Group (MYRG) is a specialty electrical contractor positioned to benefit from accelerating transmission & distribution spend and commercial electrification. Fundamentals — including $232M in free cash flow, a conservative debt profile and improving technicals above the 50-day moving average — set up a mid-term trade. Entry at $272.76, stop at $2…
Grupo Aeroportuario del Pacifico (PAC) trades below its short-term moving averages after a run-in with hurricane-related disruptions and soft passenger traffic. The stock's dividend yield (~3.3%), recent refinancing, and a clear recovery path in passenger volumes argue for a mid-term swing entry on a measured pullback. Trade setup: entry $238.00, s…
Rivian's R2 launch targets the sub-$50k mainstream EV segment and, together with improving gross margins and nascent AI/Autonomy investments, creates a tangible long-term upside while the stock trades at roughly $20.8B market cap. This trade idea is a directional long that assumes a smooth R2 production ramp and margin stabilization; it includes an…
Mastercard is evolving from an interchange-driven payments network into a software-first platform. Recent stablecoin and wallet partnerships validate the strategy; fundamentals remain strong with $17.2B free cash flow and a $462B market cap. This trade idea buys a near-term pullback to $515 with a $600 target and $485 stop for a long-term swing ove…
Infleqtion (INFQ) is a recent public-market entrant building neutral-atom quantum systems for computing, sensing and networking. A fresh integration announcement with NVIDIA NVQLink at GTC 2026 and a sub-$3.0B market cap give the stock asymmetric upside into re-rating events — but execution, capital cadence and noisy price discovery raise real near…
